Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 2
2005 2
2006 4
2007 5
2008 7
2010 3
2011 5
2012 5
2013 1
2014 2
2015 4
2016 5
2017 6
2018 1
2019 2
2020 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

50 results
Results by year
Filters applied: . Clear all
Page 1
Retinoids in clinical use.
Njar VC, Gediya L, Purushottamachar P, Chopra P, Belosay A, Patel JB. Njar VC, et al. Med Chem. 2006 Jul;2(4):431-8. doi: 10.2174/157340606777724022. Med Chem. 2006. PMID: 16848757 Review.
CYP17 inhibitors for prostate cancer therapy.
Vasaitis TS, Bruno RD, Njar VC. Vasaitis TS, et al. Among authors: njar vc. J Steroid Biochem Mol Biol. 2011 May;125(1-2):23-31. doi: 10.1016/j.jsbmb.2010.11.005. Epub 2010 Nov 17. J Steroid Biochem Mol Biol. 2011. PMID: 21092758 Free PMC article. Review.
Letter to the editor.
Njar VC. Njar VC. Expert Opin Ther Targets. 2017 Jan;21(1):9-10. doi: 10.1080/14728222.2016.1214399. Epub 2016 Jul 25. Expert Opin Ther Targets. 2017. PMID: 27428760 Free article. No abstract available.
Prospects for Clinical Development of Stat5 Inhibitor IST5-002: High Transcriptomic Specificity in Prostate Cancer and Low Toxicity In Vivo.
Maranto C, Udhane V, Jia J, Verma R, Müller-Newen G, LaViolette PS, Pereckas M, Sabharwal L, Terhune S, Pattabiraman N, Njar VCO, Imig JD, Wang L, Nevalainen MT. Maranto C, et al. Among authors: njar vco. Cancers (Basel). 2020 Nov 18;12(11):3412. doi: 10.3390/cancers12113412. Cancers (Basel). 2020. PMID: 33217941 Free PMC article.
50 results